OR7E1P

Across TCGA pan-cancer cohorts, OR7E1P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR7E1P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where OR7E1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E1P is over-expressed in tumor.

BLCA, BRCA, and STAD are the cancer types where OR7E1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	IV	+0.070	.003	3	view →
BRCA	All	II,III,IV	+0.011	.043	2	view →
STAD	All	II,III,IV	+0.016	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR7E1P–BLCA

Open the BLCA breakdown →